{"schema_version":"1","generated_at":"2026-10-28T17:36:13.019Z","data_as_of":null,"url":"https://www.findmykol.com/kol/david-spriggs","json_url":"https://www.findmykol.com/kol/david-spriggs/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"david-spriggs","name":"David Spriggs","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Boston","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1023104353"},"summary":"David Spriggs is an Oncology physician. ClinicalTrials.gov lists 15 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"trials":{"count":15,"shown":3,"withheld":13,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT05061940","title":"This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.","status":"TERMINATED","role":"Overall official","sponsor":"Repertoire Immune Medicines","source_url":"https://clinicaltrials.gov/study/NCT05061940","trial_url":"https://www.findmykol.com/trial/NCT05061940"},{"nct":"NCT04762225","title":"RPTR-168 in Patients With Human Papillomavirus Strain 16 (HPV-16) E6/E7 Positive Tumors and Melanoma","phase":"PHASE1","status":"TERMINATED","role":"Overall official","sponsor":"Repertoire Immune Medicines","source_url":"https://clinicaltrials.gov/study/NCT04762225","trial_url":"https://www.findmykol.com/trial/NCT04762225"},{"nct":"NCT03815682","title":"RPTR-147 in Patients With Selected Solid Tumors and Lymphomas","phase":"PHASE1","status":"TERMINATED","role":"Overall official","sponsor":"Repertoire Immune Medicines","source_url":"https://clinicaltrials.gov/study/NCT03815682","trial_url":"https://www.findmykol.com/trial/NCT03815682"}],"source":"trials"},"payments":{"company_count":3,"program_years":{"first":2021,"last":null},"rows_total":3,"shown":3,"withheld":0,"rows":[{"payer":"Deciphera Pharmaceuticals Inc.","program_year":2021,"amount_usd":3000,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1023104353"},{"payer":"Innocoll Incorporated","program_year":2021,"amount_usd":2600,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1023104353"},{"payer":"Chugai Pharmaceutical Co., Ltd.","program_year":2021,"amount_usd":1320,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1023104353"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1023104353","source":"payments"},"prescribing":{"data_year":2019,"areas_total":2,"areas_shown":2,"areas":[{"area":"Sensory organs","share_pct":56,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":56,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":44,"classes_total":1,"classes":[{"class":"Atypical Antipsychotic","setting":"prescribed","share_pct":44,"drugs":[{"name":"Olanzapine","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2019,"office_pct":0,"facility_pct":100},"source":"medicare"},"funding":{"award_count":3,"fiscal_years":{"first":1985,"last":2021},"rows_total":10,"shown":3,"withheld":7,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"P50CA240243","title":"Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant","fiscal_year":2021,"amount_usd":"2264107","organization":"DANA-FARBER CANCER INST","source_url":"https://reporter.nih.gov/quickSearch/P50CA240243"},{"project":"P50CA240243","title":"Career Enhancement Program (CEP)","fiscal_year":2021,"amount_usd":"133063","organization":"DANA-FARBER CANCER INST","source_url":"https://reporter.nih.gov/quickSearch/P50CA240243"},{"project":"P50CA240243","title":"Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant","fiscal_year":2020,"amount_usd":"2483069","organization":"DANA-FARBER CANCER INST","source_url":"https://reporter.nih.gov/quickSearch/P50CA240243"}],"source":"grants"},"contact":{"address_1":"55 FRUIT ST","city":"Boston","state":"MA","zip":"02114","phone":"617-726-4000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1023104353","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":13,"funding":7}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2018-08-01","collected_at":"2026-10-27T00:00:00.000Z"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2019},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}